TY - JOUR T1 - Impact of Public Health Education Program on the Novel Coronavirus Outbreak in the United States JF - medRxiv DO - 10.1101/2021.01.18.21250047 SP - 2021.01.18.21250047 AU - Enahoro A. Iboi AU - Ariana Richardson AU - Rachel Ruffin AU - DeAndrea Ingram AU - Jailyn Clark AU - Jala Hawkins AU - Maati McKinney AU - Nianza Horne AU - Reyla Ponder AU - Zoe Denton AU - Bismark Oduro AU - Lanre Akinyemi Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/20/2021.01.18.21250047.abstract N2 - The coronavirus outbreak in the United States continues to pose a serious threat to human lives. Public health measures to slow down the spread of the virus involve using a face mask, social-distancing, and frequent hand washing. Since the beginning of the pandemic, there has been a global campaign on the use of non-pharmaceutical interventions (NPIs) to curtail the spread of the virus. However, the number of cases, mortality, and hospitalization continue to rise globally, including in the United States. We developed a mathematical model to assess the impact of a public health education program on the coronavirus outbreak in the US. Our simulation showed the prospect of an effective public health education program in reducing both the cumulative and daily mortality of the novel coronavirus. Finally, our result suggests the need to obey public health measures as loss of willingness would increase the cumulative and daily mortality in the US.Competing Interest StatementThe authors have declared no competing interest.Funding StatementEAI, AR, and RR would like to acknowledge and thank our partners of The Boeing Company and the Thurgood Marshall College Fund, for their charitable, capacity grant in support of the Math RaMP Program at Spelman College, via the Boeing $|$ TMCF HBCU Investment. We would also like to acknowledge the MAA Tensor Women and Mathematics Program for support of the Math RaMP Program at Spelman CollegeAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available through the John Hopkins University COVID-19 dashboard https://github.com/CSSEGISandData/COVID-19 ER -